General Information
Version
5
Revision date
2024-05-20
Product name
IMDELLTRA
Product Synonyms
Tarlatamab-dlle
Chemical name
Anti-DLL3 half-life extended bispecific T-cell engager molecule
CAS No.
2307488-83-9
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
1-800-424-9300, 1-703-527-3887, 1-805-447-7233, 1-805-447-1000
Icons in SDS
Company Information
company name
Amgen Inc
Section 2
SECTION 2: Hazards identification
WHMIS 2015 Emergency Overview Pharmaceutical product intended for clinical and commercial manufacturing purposes only. Product contains tarlatamab-dlle, active ingredient for the treatment of small cell lung cancer (SCLC) and relapsed/refractory neuroendocrine prostate cancer (NEPC). The toxicity and potency of this chemical are not fully known. Avoid inhalation, skin contact, eye contact and accidental ingestion. Does not meet GHS classification criteria and therefore is not classified. 2.1 - Classification of the drug substance or mixture (drug product in final form, not applicable)
2.2 Label elements
Not classified
Other hazards
No information available
